These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22524172)

  • 21. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
    Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?
    Riva N; Lip GY
    Pol Arch Med Wewn; 2012; 122(1-2):45-53. PubMed ID: 22353706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.
    Mangiafico RA; Mangiafico M
    Curr Med Chem; 2012; 19(27):4688-98. PubMed ID: 22830344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic and anticoagulant therapy for atrial fibrillation.
    Dzeshka MS; Lip GY
    Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds.
    Dimitropoulos G; Rahim SMZ; Moss AS; Lip GYH
    Expert Opin Investig Drugs; 2018 Jan; 27(1):71-86. PubMed ID: 29224364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New oral anticoagulants for atrial fibrillation: a review of clinical trials.
    O'Dell KM; Igawa D; Hsin J
    Clin Ther; 2012 Apr; 34(4):894-901. PubMed ID: 22417716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents.
    Ogawa S; Koretsune Y; Yasaka M; Aizawa Y; Atarashi H; Inoue H; Kamakura S; Kumagai K; Mitamura H; Okumura K; Sugi K; Yamashita T
    Circ J; 2011; 75(7):1539-47. PubMed ID: 21666370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary prevention of ischaemic stroke in atrial fibrillation: new oral anticoagulant drugs for all?
    Foley J; Kirchhof P; Lip GY
    Curr Vasc Pharmacol; 2014 May; 12(3):373-83. PubMed ID: 24846226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.
    Deitelzweig S
    Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
    Lenchus JD
    Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
    Janzic A; Kos M
    Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of stroke in patients with atrial fibrillation.
    Olsson SB; Halperin JL
    Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic therapy in nonvalvular atrial fibrillation: a narrative review.
    Sá SP; Rodrigues RP; Santos-Antunes J; Rocha Gonçalves F; Nunes JP
    Rev Port Cardiol; 2011 Dec; 30(12):905-24. PubMed ID: 22094310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New avenues for anticoagulation in atrial fibrillation.
    Mantha S; Cabral K; Ansell J
    Clin Pharmacol Ther; 2013 Jan; 93(1):68-77. PubMed ID: 23212107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and anticoagulation therapy: different race, different risk, and different management?
    Vivas D; Olmos C; Vilacosta I
    Circ J; 2011; 75(6):1314-5. PubMed ID: 21532184
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting.
    Zheng Y; Sorensen SV; Gonschior AK; Noack H; Heinrich-Nols J; Sunderland T; Kansal AR
    Clin Ther; 2014 Dec; 36(12):2015-2028.e2. PubMed ID: 25438722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.